-
Trump turns to Venezuela playbook on Iran, but differences sharp
-
New York breaks out snow 'hot tubs' to melt winter storm snowfall
-
Anthony Joshua speaks on camera for first time since Nigeria crash
-
Apple earnings soar as China iPhone sales surge
-
Forest, Celtic head into Europa League play-offs as Villa win
-
With Trump administration watching, Canada oil hub faces separatist bid
-
What are the key challenges awaiting the new US Fed chair?
-
Trump's new Minneapolis point man vows 'smarter' operation
-
Trump says Putin to halt Kyiv strikes for week amid harsh cold
-
De Kock ton clinches T20 series for South Africa against West Indies
-
Chiles's appeal to retain Olympic bronze sent back to CAS
-
Iran threatens to hit US bases and carriers in event of attack
-
If not now, when? LeBron tears stoke retirement talk
-
Ex-OPEC president denies bribe-taking at London corruption trial
-
Another Arctic blast bears down on US as snow cleanup drags on
-
Iran's IRGC: the feared 'Pasdaran' behind deadly crackdown
-
Israeli settler leader lauds Jewish prayer at contested West Bank tomb
-
Iran blasts EU 'mistake' after Guards terror designation
-
Trump says Putin agreed not to attack freezing Kyiv for a week
-
US Senate rejects vote to avert government shutdown
-
Moscow records heaviest snowfall in over 200 years
-
Polar bears bulk up despite melting Norwegian Arctic: study
-
Waymo gears up to launch robotaxis in London this year
-
Colombia restricts import of drones used in explosives attacks
-
French IT group Capgemini under fire over ICE links
-
US border chief says not 'surrendering' immigration mission in Minneapolis
-
Oil jumps on Trump's Iran threat; gold retreats from highs
-
Melania Trump premieres multi-million-dollar documentary
-
Holders PSG, Real Madrid among clubs awaiting Champions League play-offs draw
-
England look to fine tune for T20 World Cup with Sri Lanka series
-
US Senate vote to avert government shutdown expected to fail
-
Colombian president angers churches with Jesus sex comments
-
Turkey to offer mediation in US-Iran showdown
-
World Cup skiing returns to Crans-Montana after deadly fire
-
EU designates Iran Guards as 'terrorist organisation'
-
Czechs wind up black coal mining in green energy switch
-
Where does Iraq stand as US turns up heat on Iran?
-
Vietnam designer makes history as Paris Haute Couture wraps up
-
Denmark hails 'very constructive' meeting with US over Greenland
-
US border chief says not 'surrendering' immigration mission
-
EU to put Iran Guards on 'terrorist list'
-
Pegula calls herself 'shoddy, erratic' in Melbourne semi-final loss
-
All hands on deck: British Navy sobers up alcohol policy
-
Sabalenka says Serena return would be 'cool' after great refuses to rule it out
-
Rybakina plots revenge over Sabalenka in Australian Open final
-
Irish Six Nations hopes hit by Aki ban
-
Britain's Starmer hails 'good progress' after meeting China's Xi
-
Parrots rescued as landslide-hit Sicilian town saves pets
-
Gold surges further, oil jumps on Trump's Iran threat
-
No handshake as Sabalenka sets up repeat of 2023 Melbourne final
Dogs die as South Africa snake antivenom shortage bites
Zarza, a much-loved Staffordshire terrier, ended up at a South African animal hospital with a bite from a Mozambique spitting cobra on her snout.
The snake's powerful venom can stop the breathing muscles from working, but normally the bites are treatable with an antidote.
The problem, say South African veterinarians, is that they currently have virtually no vials of the antiserum left.
"We've been out of antivenom for quite some months now," said Dean de Kock, a vet at the Valley Farm Animal Hospital in Pretoria, where Zarza was treated but eventually died.
Vets and snake experts say the shortage started getting serious towards the end of last year -- though the authorities are denying there is a problem.
"Snakebite antivenom is available in the country," the National Health Laboratory Service (NHLS), a government body in charge of antidote production, told AFP.
Experts in the field disagree.
- A 'countrywide shortage' -
In April, a group of snakebite treatment specialists pleaded with the health minister over what they described as "a major health risk".
While the supply problems may be easing in some quarters, vets say they are still struggling.
Hospitals treating humans get priority when any new doses come available, said Johan Marais, a herpetologist -- specialist in reptiles and amphibians -- who heads the African Snakebite Institute.
"At the moment, if you're a veterinarian, you cannot get antivenom," said Marais, 65.
Speaking from his headquarters in Pretoria, he casually handled a black mamba during his conversation with AFP.
He said he receives up to a dozen calls a day from desperate animal doctors and dog owners looking for antidotes.
"If your dog gets a serious snakebite today, there's a likelihood it's going to die," Marais said.
Alan Kloeck, of the South African Veterinary Association, confirmed Marais's remarks, describing a "countrywide shortage" with vets unable to get their hands on the antiserum they needed.
- Horse blood, spitting cobras -
South Africa is home to about 160 species of snakes, many of them poisonous.
South African Vaccine Producers -- a NHLS subsidiary and the only antivenom maker in the country -- produces two antidotes.
One can treat bites from 10 snakes including the cape cobra, the puff adder and the green mamba, while another is for relatively rare boomslang bites.
Making the antiserums is a laborious process, said Mike Perry of African Reptiles and Venom, a venom-extraction firm in Centurion, outside Johannesburg, that houses around 900 snakes in small glass cages.
He said his team forces the hissing reptiles to spit out their poison by forcing them to bite a glass jar.
Small quantities of the toxins are then injected into horses, which over time develop immunity.
Their plasma is then harvested and processed to make the serum.
But that process requires constant refrigeration, and the production backlog has been blamed in large part on South Africa's energy crisis, which has caused repeated power blackouts.
In April, NHLS said it required "a consistent and dependable power supply" to produce antivenom.
The continuous switchover to generators during outages interrupted production and affected stockpiles, it said, forcing it to invest in backup power systems and renewable energy.
- 'Last vial' -
Last week, NHLS said it had increased manufacturing in recent months.
Since January, it said, it had delivered antivenom to more than 230 institutions, including hospitals and veterinary clinics, fulfilling all orders apart from "a small backlog" affecting a provincial depot.
But de Kock, whose veterinary practice is in a different province, has not received any shipments since December. For a while, they were using expired doses from other hospitals, but these too have dried up.
"We have used the last vial on Sunday evening," he said last week.
Over the past three months, the hospital treated 25 dogs for snakebites.
Of the 16 who could get expired antivenom, only one did not survive, while six of the nine who could not get doses died.
Zarza was among them, dying in May after a two-day struggle on a ventilator.
"It's tough," said de Kock, 53. "You're doing everything you can but the vital thing that you actually need is the antivenom, and you don't have that".
His hope was that the austral winter months, when snakes are less active, would bring some relief.
O.Krause--BTB